Browsing by Subject "ANTIVIRAL THERAPY"
Now showing items 1-2 of 2
-
Entecavir monotherapy for lamivudine-refractory chronic hepatitis B
(2008)Evaluation of: Sherman M, Yurdaidin C, Simsek H et al. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical and serology outcomes through 96 weeks. Hepatology 48, 99-108 (2008). ... -
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
(2012)Despite a decline in cases of acute hepatitis B and the low hepatitis B virus (HBV) chronicity rates in adults, still some patients progress to HBV-related fulminant liver failure. In this review, we discuss treatment ...